Add Yahoo as a preferred source to see more of our stories on Google. AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the ...

The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some experts say it is a milestone that could help bring the world closer to ending ...

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including attending doctor's visits every three months and – most importantly – consistency.

Kenya's health authorities have begun administering lenacapavir, a long-acting HIV prevention drug delivered by injection that offers protection for six months. The treatment will be available free ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Deputy President welcomes rollout of HIV prevention injection Deputy President Paul Mashatile has hailed South Africa’s upcoming rollout of Lenacapavir as a potential game-changer in the country’s ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new long-lasting prophylactic treatment for HIV-1 that is administered once every 6 months. Lenacapavir (Yeytuo, Gilead ...

The Federal Government has confirmed the arrival of the long-acting HIV prevention injection, Lenacapavir, marking a major ...

Nigeria has received Lenacapavir, a twice-yearly HIV prevention injection, to expand prevention options and accelerate ...

AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the spread of the virus. This summer, the FDA approved Gilead’s lenacapavir, ...